2.97 USD
▲+0.11+3.85%
盘后 3.01 +1.19%
2026-11-20
市值
$11.33M
市盈率
—
EPS
-2.99
股息率
—
52 周区间
1.92 – 16.96
成交量
32.64K
Beta
1.73
目标价
—
52W 低 1.9252W 高 16.96
价格走势
公司简介
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.